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Objective: Percutaneous coronary intervention is increasingly used to treat multivessel coronary artery disease.
Coronary artery bypass graft procedures have decreased, and as a result, percutaneous coronary intervention has
increased. The overall impact of this treatment shift is uncertain. We examined the in-hospital mortality and com-
plication rates for these procedures in California using a combined risk model.
Methods: The confidential dataset of the Office of Statewide Health Planning and Development patient discharge
database was queried for 1997 to 2006. A risk model was developed using International Classification of Dis-
eases, Ninth Revision, Clinical Modification procedures and diagnostic codes from the combined pool of isolated
coronary artery bypass graft and percutaneous coronary intervention procedures performed during 2005 and
2006. In-hospital mortality was corrected for ‘‘same-day’’ transfers to another health care institution. Early failure
rate was defined as in-hospital mortality rate plus reintervention for another percutaneous coronary intervention or
cardiac surgery procedure within 90 days.
Results: Coronary artery bypass graft volume decreased from 28,495 (1997) to 15,520 (2006), whereas percu-
taneous coronary intervention volume increased from 38,098 to 53,703. Risk-adjusted mortality rate decreased
from 4.7% to 2.1% for coronary artery bypass graft procedures and from 3.4% to 1.9% for percutaneous cor-
onary intervention. Expected mortality rate increased for both procedures. Early failure rate decreased from
13.1% to 8.0% for percutaneous coronary intervention and from 6.5% to 5.4% for coronary artery bypass graft.
For the years 2004 and 2005, the risk of recurrent myocardial infarction or need for coronary artery bypass graft
during the first postoperative year was 12% for percutaneous coronary intervention and 6% for coronary artery
bypass grafts.
Conclusion: This study shows that as volume shifted from coronary artery bypass grafts to percutaneous coro-
nary intervention, expected mortality increased for both procedures. Risk-adjusted mortality rate decreased for
both procedures, more so for coronary artery bypass grafts, so that corrected in-hospital mortality rates essentially
equalized at approximately 2.0% in 2006. The post-procedural risk of reintervention, death, or myocardial infarc-
tion within the first year was twice as high for percutaneous coronary intervention as for coronary artery bypass
grafts.Two important events occurred in 2003 that influenced the
practice of coronary artery revascularization in California:
the introduction of drug-eluting stents and public reporting
of outcomes of coronary artery bypass procedures. Concur-
rently, theCalifornia Society of Thoracic Surgeons introduced
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doi:10.1016/j.jtcvs.2009.03.0691100 The Journal of Thoracic and Cardiovascular Sua quality improvement program, known as the California Car-
diac Surgery and Intervention Project. This project used the
available reporting systems to study outcomes of cardiac sur-
gery and interventions and evaluate best practices.
The public reporting system, the California CABG Out-
comes Reporting Program, reported only on isolated coronary
artery bypass graft (CABG) procedures. The California
Cardiac Surgery and Intervention Project therefore used the
patient discharge database maintained by the Office of State-
wide Health Planning and Development (OSHPD-PDD) to
collect outcome information on all cardiac surgery and percu-
taneous coronary intervention (PCI) procedures. Initial studies
found that mortality rates for cardiac surgery and PCI proce-
dures in the years before 2003 were higher in California com-
paredwithNewYork, a state with a public reporting system in
place since 1991.1After the introduction of theCalifornia pub-
lic reporting system in 2003, we found that the mortality rates
for CABG and valve procedures declined.2rgery c November 2009
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CABG ¼ coronary artery bypass graft
MI ¼ myocardial infarction
OSHPD-PDD ¼ Office of Statewide Health
Planning and Development
PCI ¼ percutaneous coronary intervention
RAMR ¼ risk-adjusted mortality rate
After the widespread introduction of drug-eluting stents for
PCI, and the resulting decrease in restenosis, PCI has been
increasingly used to treat multivessel coronary artery dis-
ease, and the number of CABG procedures has declined.
The overall impact of this treatment shift is uncertain. We
examined the in-hospital mortality rates and post-hospital
outcomes for PCI and CABG in California using the
OSHPD-PDD to collect data on all programs that performed
both procedures during 1997 to 2006.
MATERIALS AND METHODS
The confidential dataset of the OSHPD-PDD was queried for 1997 to
2006. A riskmodelwas developed using demographic variables and Interna-
tional Classification of Diseases, Ninth Revision, Clinical Modification pro-
cedure and diagnostic codes from the combined pool of isolated CABG and
PCI procedures based on 2005 and 2006 only. In-hospital mortality was de-
termined for the index hospitalization and corrected for deaths that occurred
after ‘‘same-day’’ transfers to another healthcare facility. Ninety-day postdi-
scharge outcomes were determined, including readmissions for death or re-
intervention (any PCI or CABG). Out-of-hospital deaths were not included
in the mortality rates. Because of loss in follow-up, for the entire time period
from 1997 to 2006, we had to exclude 7.551 patients (1%) with a CABG or
PCI because we were unable to determine their last nontransfer disposition.
For patientswithmultiple admissions for the same procedure, the first admis-
sion was included in the study as the index hospitalization.
Multiple variable logistic regression was used to fit a model for the 2 out-
comes. The model included the risk factors listed in Appendix A. Because
the effect of a risk factor on mortality differs by surgery type, with the ex-
ception of the demographic variables, we fitted a term for each of the risk
factors listed above separately for the patients with a CABG or PCI. For in-
stance, cardiogenic shock increased the risk of mortality by a factor of 5 in
those undergoing PCI and by a factor of 15 in those undergoing CABG.
In a previous report,3 one of the authors described the variation in incidence
of risk factors between the CABG and PCI groups. In this study, propensity
analysis was also used to study the influence of procedure choice on outcomes.
RESULTS
In-Hospital Mortality
We initially compared in-hospital mortality rates for
CABG and PCI using a riskmodel obtained from a combined
pool of procedures performed during 2005 and 2006. This
analysis, using only the index hospitalization, showed that
in-hospital mortality rates decreased markedly during the
10-year period for CABG but only slightly for PCI (Table 1).
When in-hospital mortality was corrected for deaths occur-
ring after ‘‘same-day’’ transfers to another healthcare facility,
the RAMR in 2006was 2.09% for CABG and 1.90% for PCIThe Journal of Thoracic and C(Table 2, Figure 1). CABG volume decreased from 28,249
(1997) to 14,782 (2006), and PCI volume increased from
37,964 to 52,764. The observed in-hospital mortality for
CABGdecreased from3.63% (1997) to 2.05% (2006) and re-
mained stable for PCI at 1.6%. Expected mortality, predicted
from the 2005 to 2006 risk model, increased 27% from 1997
to 2006 for CABG and 71% for PCI. The risk-adjusted mor-
tality rate (RAMR) decreased markedly over the entire period
for CABG. The RAMR for PCI decreased from 1997 to 1999,
but decreased only slightly thereafter.
Correction of in-hospital mortality for ‘‘same-day’’ trans-
fers compares favorably with ‘‘operative mortality’’ as de-
termined by the Society of Thoracic Surgeons’ definition.
Operative mortality includes death during the index hospi-
talization plus any death within 30 days but does not include
in-hospital deaths occurring beyond 30 days after transfer to
another facility. The OSHPD California CABG Outcomes
Reporting Program reports, using the ‘‘operative mortality’’
definition and validating deaths by linkage to the California
death file (available at: http://www.oshpd.ca.gov/HID/Prod
ucts/Clinical_Data/CABG/), counted 1766 deaths (3.08%)
among 57,316 patients undergoing isolated CABG from
2003 to 2005. In the present report, without counting read-
mission or out-of-hospital deaths within 30 days but adding
all deaths in transferred patients, 1723 deaths (3.05%)
among 56,475 patients undergoing isolated CABG were
counted during the same time period.
Early Failure Rate
The early failure rate for PCI and CABG was determined
by combining mortality with reintervention for another re-
vascularization procedure (PCI or CABG surgery) within
90 days after the index procedure (Table 3, Figure 2).
The early failure rate decreased for both procedures, more
significantly for PCI. This decrease for PCI was observed
despite the fact that the data included procedures performed
for nontarget vessel revascularization.
TABLE 1. Observed in-hospital mortality rates after coronary artery
bypass graft surgery and percutaneous coronary intervention,
California, 1997–2006 (not corrected for ‘‘same day’’ transfers)
Surgery
year
CABGs PCIs
N Events Event% N Events Event%
1997 28,495 883 3.10 38,098 571 1.50
1998 28,403 846 2.98 42,449 588 1.39
1999 27,897 827 2.96 44,178 610 1.38
2000 28,091 801 2.85 45,329 641 1.41
2001 26,163 772 2.95 47,876 701 1.46
2002 24,676 660 2.67 49,162 701 1.43
2003 21,519 518 2.41 52,292 719 1.37
2004 19,305 525 2.72 54,339 807 1.49
2005 17,074 409 2.40 54,666 787 1.44
2006 15,520 268 1.73 53,703 758 1.41
CABG, Coronary artery bypass graft; PCI, percutaneous intervention.ardiovascular Surgery c Volume 138, Number 5 1101
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DTABLE 2. Observed and risk-adjusted corrected in-hospital mortality rates after isolated coronary artery bypass graft surgery or percutaneous
coronary intervention, California, 1997–2006
Year Surgeries
In-hospital
deaths %Mortality
% Expected
mortality RAMR
RAMR
95% LCL 95% UCL
Isolated CABGs
1997 25,830 938 3.63 1.66 4.71 4.41 5.02
1998 28,136 999 3.55 1.72 4.43 4.16 4.71
1999 27,623 977 3.54 1.75 4.35 4.08 4.63
2000 27,806 911 3.28 1.76 4.00 3.74 4.27
2001 25,864 917 3.55 1.82 4.18 3.91 4.46
2002 24,318 761 3.13 1.89 3.55 3.31 3.82
2003 21,124 630 2.98 1.95 3.29 3.03 3.55
2004 18,844 607 3.22 2.04 3.39 3.12 3.67
2005 16,507 486 2.94 2.06 3.06 2.80 3.35
2006 14,782 303 2.05 2.11 2.09 1.86 2.34
PCIs
1997 34,487 567 1.64 1.04 3.39 3.11 3.68
1998 42,261 654 1.55 1.05 3.16 2.93 3.42
1999 43,921 701 1.60 1.48 2.32 2.15 2.50
2000 45,057 715 1.59 1.52 2.24 2.08 2.41
2001 47,605 781 1.64 1.56 2.25 2.10 2.42
2002 48,870 784 1.60 1.59 2.16 2.01 2.32
2003 51,931 806 1.55 1.64 2.04 1.90 2.18
2004 53,916 901 1.67 1.65 2.17 2.03 2.32
2005 54,125 883 1.63 1.69 2.08 1.94 2.22
2006 52,762 835 1.58 1.78 1.90 1.78 2.04
RAMR, Risk-adjusted mortality rate; CABG, coronary artery bypass graft; LCL, lower confidence limit;UCL, upper confidence limit; PCI, percutaneous coronary intervention. The
corrected in-hospital mortality rate includes mortality after a same-day transfer. Approximately 1% of patients are lost to follow-up because it was not possible to determine their
post-transfer disposition. The California corrected in-hospital mortality rate after isolated CABG surgery or PCI for 2005/2006 was 2.15 and is used as the reference level for the
RAMR. The RAMR was computed on the basis of a multiple logistic regression model fit to the 2005/2006 data including isolated CABGs and PCIs.Late Failure Rate
Patients undergoing PCI or CABG during 2004 and 2005
were followed to determine the incidence of readmission for
acute myocardial infarction (MI) or need for another CABG
(‘‘late failure rate’’) during the first year after the index pro-
cedure (Table 4). This risk of acute MI or readmission for
CABG within the first year was approximately 12% for
PCI and 6% for CABG.
Individual Hospital Variation
The number of hospitals performing both PCI and CABG
each year varied between 118 and 122. As the gap narrowed
in early mortality, the number of hospitals with higher mor-
tality after PCI than after CABG surgery increased from 9 in
1997 to 58 in 2006. In 2006, 48% of California hospitals had
higher unadjusted in-hospital mortality for PCI than CABG.
In 2006, 41 hospitals (34%) had higher risk-adjusted mortal-
ity after PCI compared with CABG.
Hospitals performing a lower volume of CABG proce-
dures in 2005 and 2006 tended to have higher mortality after
CABG surgery, but not for PCI. Table 5 shows a comparison
of hospitals performing fewer than 100 CABG surgeries per
year during 2005 and 2006 with those performing at least
100. The CABG risk-adjusted in-hospital mortality rate
was approximately 21% higher in low-volume hospitals,1102 The Journal of Thoracic and Cardiovascular Swhereas the PCI RAMR was only 12% higher. The differ-
ence in mortality for low-volume versus high-volume hospi-
tals after CABG surgery or PCI is not statistically
significant. The PCI to CABG volume ratio was 5:1 for
low-volume hospitals and 3:1 for high-volume hospitals.
DISCUSSION
Several recent reviews have examined the comparative
outcomes of PCI and CABG procedures. A meta-analysis
0
1
2
3
4
5
6
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
CABG RAMR PCI RAMR
FIGURE 1. Risk-adjusted in-hospital mortality rate after isolated CABG
surgery or percutaneous coronary intervention, California, 1997–2006.
The dotted lines show the 95% confidence limits of the risk-adjusted mor-
tality rate. CABG, Coronary artery bypass graft; RAMR, risk-adjusted mor-
tality rate; PCI, percutaneous coronary intervention.urgery c November 2009
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DTABLE 3. Observed and risk-adjusted 90-day in-hospital mortality/reintervention rates after isolated coronary artery bypass graft surgery or
percutaneous coronary intervention, California, 1997–2006
Year Surgeries INH/RE90 % INH/RE90 % INH/RE90 RAER
RAER
95% LCL 95% UCL
Isolated CABGs
1997 25,507 1127 4.42 5.11 6.49 6.12 6.88
1998 27,774 1223 4.40 5.08 6.51 6.15 6.88
1999 27,270 1200 4.40 5.17 6.39 6.03 6.76
2000 27,452 1124 4.09 5.11 6.01 5.67 6.37
2001 25,578 1143 4.47 5.13 6.54 6.16 6.93
2002 24,091 1027 4.26 5.13 6.24 5.86 6.63
2003 21,076 846 4.01 5.15 5.85 5.46 6.26
2004 18,813 818 4.35 5.16 6.33 5.90 6.77
2005 16,589 635 3.83 5.18 5.55 5.13 6.00
2006 11,626 435 3.74 5.23 5.37 4.88 5.90
PCI
1997 33,739 3718 11.02 6.32 13.08 12.67 13.51
1998 41,388 4165 10.06 6.35 11.90 11.55 12.27
1999 42,870 4155 9.69 7.53 9.67 9.38 9.97
2000 43,835 4090 9.33 7.61 9.21 8.93 9.50
2001 46,564 4272 9.17 7.68 8.97 8.70 9.24
2002 47,918 4393 9.17 7.76 8.87 8.61 9.14
2003 51,020 4430 8.68 7.82 8.34 8.09 8.59
2004 52,947 4297 8.12 7.87 7.74 7.51 7.98
2005 52,945 4402 8.31 7.96 7.84 7.61 8.08
2006 39,955 3480 8.71 8.19 7.99 7.72 8.26
RAER, Risk-adjusted event rate; CABG, coronary artery bypass graft; LCL, lower confidence limit; UCL, upper confidence limit; INH/RE90, 90-day in-hospital mortality/reinter-
vention rate; PCI, percutaneous coronary intervention. The in-hospital mortality/reintervention rate includes mortality after a same-day transfer and any readmissions for reinter-
ventions within 90 days. Approximately 5% of patients are lost to follow-up. The California in-hospital mortality/reintervention rate after isolated CABG surgery or PCI for 2005/
2006 was 7.51 and is used as the reference level for the risk-adjusted event rate. The risk-adjusted event rate was computed on the basis of a multiple logistic regression model fit to
the 2005/2006 data, including isolated CABGs and PCIs.of long-term (up to 5 years) outcomes in 4 randomized
controlled trials of PCI with stenting versus CABG for
multivessel coronary artery disease found that PCI was asso-
ciated with an increase in subsequent revascularization (PCI
or CABG) and major adverse cardiovascular events relative
to CABG.4
Taggart5 also reviewed meta-analyses and found that
drug-eluting stents have not improved survival or freedom
from MI compared with CABG. He concluded that CABG
remains the best therapy in terms of improved survival and
freedom from reintervention for most patients with proximal
left anterior descending, multivessel, and left main-stem cor-
onary artery disease. Other studies have pointed out that al-
though early outcomes of PCI using drug-eluting stents and
CABG were similar, PCI had the advantage of shorter hos-
pital stays and fewer complications.6 Longer-term data have
found CABG to be associated with fewer recurrences of
angina and MI, and less need for intervention, than PCI.7
This study shows that over time in California, early out-
comes of PCI and CABG have become comparable. Fol-
low-up through 90 days to 1 year indicates a higher
reintervention rate for PCI. Much of the reintervention rate
is due to nontarget vessel reintervention, which we could
not distinguish in the present data. Tables 2 and 3 suggestThe Journal of Thoracic and Cthat the introduction of stenting may have had an impact
on early outcomes in the 1997 to 1999 period, whereas the
introduction of drug-eluting stents in 2003 may have had
a lesser effect.
The New York public reporting registry has been studied
extensively. Hannan and colleagues8 reported that for pa-
tients with multivessel disease, CABG continues to be asso-
ciated with lower mortality rates than does treatment with
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FIGURE 2. Risk-adjusted in-hospital mortality/90-day readmission rate
after isolated CABG surgery or percutaneous coronary intervention, Califor-
nia, 1997–2006. The dotted lines show the 95% confidence limits of the
risk-adjusted mortality rate. CABG, Coronary artery bypass graft; RAMR,
risk-adjusted mortality rate; PCI, percutaneous coronary intervention.ardiovascular Surgery c Volume 138, Number 5 1103
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DTABLE 4. Comparison of one-year outcomes between percutaneous coronary intervention and isolated coronary artery bypass graft, 2004–2005
Year
PCI CABG
P valueN Mean% (95% CI) N Mean% (95% CI)
Post-procedural MI 2004 53,089 9.99 (9.93–10.04) 20,677 6.00 (5.91–6.09) <.0001
2005 52,535 9.88 (9.83–9.93) 19,128 5.73 (5.64–5.82) <.0001
Readmission for CABG 2004 53,089 2.22 (2.21–2.23) 20,677 0.20 (0.19–0.21) <.0001
2005 52,535 2.16 (2.15–2.17) 19,128 0.21 (0.20–0.22) <.0001
Operative mortality 2004 53,089 2.11 (2.07–2.15) 20,677 3.23 (3.17–3.29) <.0001
2005 52,535 1.97 (1.93–2.01) 19,128 3.00 (2.94–3.06) <.0001
Length of stay 2004 53,089 3.12 (3.04–3.20) 20,677 9.91 (9.83–9.99) <.0001
2005 52,535 2.98 (2.91–3.05) 19,128 9.86 (9.80–9.93) <.0001
PCI, Percutaneous coronary intervention; CABG, coronary artery bypass graft; CI, confidence interval; MI, myocardial infarction.drug-eluting stents and is associated with lower rates of
death or MI and repeat revascularization.8 Other studies
noted that public reporting in New York was associated
with reluctance to perform PCI in high-risk patients.9 Signif-
icant differences in case mix between patients undergoing
PCI in Michigan and New York were found that result in
marked differences in unadjusted mortality rates.10 It was
believed that a propensity in New York toward not
intervening on higher-risk patients because of fear of public
reporting of high mortality rates was the cause of lower
mortality for PCI in New York compared with Michigan.
The present study does not find evidence that the introduc-
tion of public reporting in California is associated with a re-
luctance to perform CABG procedures in high-risk patients.
Outcomes reporting may have encouraged more attention to
best practices, because CABGmortality decreased while ex-
pected mortality increased. PCI in-hospital mortality rates in
California are similar to those in other states and in countries
that do not have public reporting programs.2,9 Public report-
ing of PCI procedures in California might have a similar im-
pact on outcomes as it apparently has had in New York.
Individual hospital data found a predominance of low-
volume programs. Of 118 sites performing both PCI and
CABG during 2005 and 2006, 62 performed less than
100 CABG procedures per year. As noted in our previous
studies1 and in public reports from California (available at:
http://www.osphd.ca.gov/HQAD/Outcomes/Studies/cabg),
no statistically significant relationship has been found be-
tween the volume of CABG procedures and risk-adjusted
mortality for surgeons or hospitals. In the present study,
lower-volume sites had higher mortality for CABG in
2005 and 2006 compared with higher-volume hospitals,
whereas PCI mortality rates did not differ as much.1104 The Journal of Thoracic and Cardiovascular SuHowever, the differencebyvolumewas not statistically signif-
icant. Lower-volume sites also performed a relatively higher
number of PCI procedures comparedwith CABG procedures,
suggesting that these programs may have a more aggressive
approach to interventional procedures. In previous studies
we found that a ratio of PCI to CABG more than 2:1 was as-
sociated with an increase in CABGmortality.1 Further studies
of surgeon and hospital volumemay clarify the effect of more
aggressive PCI strategies on CABG mortality.
This study shows the strengths and limitations of using an
administrative hospital discharge database for outcomes
studies. Strengths include the completeness (all patients in-
cluded), consistency of coding, and ability to follow patients
through subsequent admissions, thus collecting all deaths
and complications except the few that occur out of hospital.
Weaknesses include limited ability to subset patients and the
absence of clinical data on organ system function, such as
myocardial contractility and pulmonary disease. We there-
fore chose to look only at the total experience with PCI
and isolated CABG procedures in California, with the as-
sumption that the choice of procedure was random, although
in many cases it was not. In previous studies we found that
propensity analysis, for example, did not show major differ-
ences in outcomes when patients were analyzed in quintiles
according to risk factors.3
Narrowing the in-hospital outcome gap between PCI and
CABG should affect the decision about which procedure is
appropriate for more complicated multivessel disease pa-
tients, because the post-hospital risk of repeat revasculariza-
tion and MI is higher with PCI. However, the incentive to
perform a less-invasive procedure is a powerful motivator
for both patient and provider. Only a clear and robust body
of evidence-based data are likely to change clinical practice.TABLE 5. Risk-adjusted in-hospital mortality rate after isolated coronary artery bypass graft surgery and percutaneous coronary intervention for
low- and high-volume hospitals, California, 2005–2006
Subgroup No. of hospitals PCI annual volume CABG annual volume PCI RAMR CABG RAMR
Low volume (<100 CABGs/y) 62 282  187 58  27 2.07 2.96
High volume (100 CABGs/y) 58 579  362 197  139 1.94 2.50
PCI, Percutaneous coronary intervention; CABG, coronary artery bypass graft; RAMR, risk-adjusted mortality rate. The differences in the RAMRs for low- and high-volume
hospitals are not statistically significant for the CABG or PCI group.rgery c November 2009
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This study shows that as volume shifted from CABG to
PCI from 1997 to 2006, expected mortality increased for
both procedures. In-hospital mortality decreased markedly
for CABG and remained stable for PCI, leading to a smaller
mortality gap for the 2 interventions in 2006. The need for
repeat revascularization decreased, but remained signifi-
cantly higher for PCI compared with CABG. During the first
year after the index procedure, the risk of acute MI or need
for repeat CABG was also higher for PCI. Overall, RAMR
decreased for patients undergoing coronary revasculariza-
tion procedures in California from 1997 to 2006. However,
late procedure failure has persisted, especially for PCI.
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Discussion
Dr Gabrial Aldea (Seattle, Wash). Decreased CABG mortality
despite increased patient acuity and complexity over the past de-
cades is indisputable and laudable. These findings were previously
published by the authors. Parallel national trends presented at this
meeting reviewing the national inpatient sample, the Society of
Thoracic Surgeons database, our own state of Washington Clinical
Outcomes Assessment Program database with more than 160,000
patients treated in the past decade, which incidentally does combineThe Journal of Thoracic and Call CABG and PCI procedures in a single database, and those of
other multiple states. Also indisputable is the increase in the num-
ber of PCI procedures and the increasing ratio of PCI to CABG over
the same decade. I have no issues with the data, but I do have some
issues with the interpretation of the data or the suggestion that this
narrow gap will somehow influence treatment assignment. I have
several comments and 2 questions.
Despite the marked change in treatment that continues unabated
after the introduction of bare metal stents and certainly preceding
drug-eluting stents, PCI and CABG still treat very different popu-
lations. In the State of Washington for CABG, more than 95% of
the patients treated with coronary bypass surgery have 3-vessel dis-
ease of the left main and the average number of grafts is 3.4 grafts
per patient. This is compared with only 15% of patients treated with
PCI presenting with 3-vessel disease of the left main, and the aver-
age number of vessels is 1.2. Assignment to PCI and CABG sur-
gery is also changing over this time period. Acute MI therapy has
evolved dramatically in the last several years, preferentially treating
acute MIs with immediate (so-called primary) PCI rather than lytic
therapy or CABG, specifically targeting 1 and rarely 2 culprit le-
sions with a specific more limited or focused treatment strategy
to minimize the morbidity of the acute MI rather than achieve com-
plete revascularization. In fact, in our own database, acute MI ther-
apy represents 30% of all PCIs, and that is a growing incidence.
Finally, medical therapy and perhaps the biology of disease have
also evolved dramatically over this period of time with the introduc-
tion of statins, more effective and more routine antiplatelet therapy,
and stricter more effective glycemic diabetic control, decreasing the
morbidity andperhaps the incidence of somesubsets of this condition.
Given these observations, I have 2 questions for you. Given the
current approach for target lesion revascularization, particularly in
unstable angina or acute MI, is it not expected that mortality rates
for PCI and specifically reintervention rates either on the same or
untreated vessels should increase? The correlation to this question
is whether a patient who presents for repeat intervention 90 days
after an acute MI really represents a true failure rate? Is the risk
at reintervention not lower?
Dr Carey. The answer is that we had to lump everything to-
gether for the PCIs, and so the number of reinterventions is proba-
bly closer to half. It was not going to be easy to subset patients in
this kind of a database, so we simply lumped them all together.
We do understand that the PCI group is a lower risk group because
of some of the factors that you mentioned, but we just thought it
was interesting that despite the similar mortality rates, at least the
early risk of any of these procedures is basically the same, and of
course this has been reported by other groups as well.
Dr Aldea.The second question I have for you is, I expect the state
or national observed/expected ratios to be equal to 1. Yours are not.
Is it appropriate therefore to generate a combinedmodel for PCI and
CABGbased on the last 2 years, 2005 and 2006, and retrospectively
apply them to the entire cohort? This gives a significant discrepancy
between the observed and the predicted or risk-adjusted mortality.
This can artificially create what I call the Garrison Keillor Lake
Wobegon principle, wherein all men are strong and all children
above average. Your predictive model actually predicts the ob-
served/expected ratios accurately only for the last 2 years.
Dr Carey. The reason we did it this way, and of course I have 2
PhDs working on this (and they tend to confuse me daily with theirardiovascular Surgery c Volume 138, Number 5 1105
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Dstatistical work) who wanted to compare the mortality rates over
time, was to use 1 risk model over the entire 10-year period. It
would have seemed to me to do a different risk model for each
year, but then the years would not have been comparable. We
were trying to show the difference between PCI and CABG over
time rather than the actual specific differences between certain
groups of patients undergoing PCI and CABG.
Dr David Follette (Sacramento, Calif). Joe, I rise to congratu-
late on an extremely well presented study and to point out to the au-
dience that Dr Carey was head of the California STS for more than
20 years and worked closely with past-president Dr Harlan in 2000
for his presidential address and his 2 associates, Dr George Miller
and Dr ______, and has made a huge contribution and dedication of
his time and effort to a system that without his leadership, Califor-
nia would be in a lot worse shape in terms of the reporting of the
data. I rise to thank you, Joe, for those 20 years of diligence and
working with our other colleagues.
We are only looking at a small segment ofwhat is being done.We
are looking at isolated coronary bypass. Thus, I have 1 important
question. Is there any way that you have looked at the addition of
other procedures, such as an isolated mitral valve ring, in a high-
risk patient who has modest or mild mitral regurgitation that may
put somebody that was a high-risk patient in a different group that
you are not looking at. Is there any way in our current state of affairs
we can see if there has been a trend to add to the coronary bypass
surgery to shift them out of the reporting group into another group?
Dr Carey. It can be done. I am not sure how well we could sub-
set patients using this administrative database. We can probably do
it in the state public database because the public report, although it
only reports isolated CABG, requires all CABG procedures to be
reported to the state. There is a move afoot to do some work on
the nonisolated CABG procedures. Of course we are only collect-
ing 54 elements for risk factors in the state report, and I do not know
if we would be able to subset the mitral valve cases the way you
would really need to. You would have to use the STS database
for that, but in my opinion the STS database needs a lot of work
in terms of making it accurate, because they are missing many
deaths, especially these mitral valve cases. It takes them 3 months
to die, as you well know.
Dr Joseph Cleveland (Denver, Colo). Dr Carey, I enjoyed your
talk and I wanted to get you to flush out your comments a little bit
on one of your conclusions that public reporting was efficacious be-
cause this is a 10-year cohort, but as I understand in the introduction
I think public reporting occurred only in 2003. How can you tie in
the fact that public reporting of these data may or may not have had
any potential impact in terms of decreasing observed/expected ra-
tios and things like that, particularly with the constant risk model
when it has not changed when things may have changed with the
risk of the patients? Can you comment on that?
Dr Carey. I think you are right; it is a little bit of backward think-
ing. We are waiting for our 2007 data, and it will be interesting to
see whether the numbers stay where they are or maybe even keep
going down, but this precipitous decrease in mortality statewide
has to have some explanation. We are not really changing our tech-
niques. It is pretty much the same surgeons. We have not imported
a whole new team of surgeons from New York or somewhere1106 The Journal of Thoracic and Cardiovascular Suwhere they are getting better outcomes. Just in thinking backwards
over what happens with public reporting and talking to the doctors
around the state, I do think they are being a little more careful. They
are being a little more selective, although it looks like our expected
mortality keeps going up. The other thing is in New York, the PCI
mortality is half of what it is in California. The fact that the PCI
mortality stays the same in California and stays low in New York
may be because cardiologists are more selective in New York.
This makes me think that if we had public reporting of PCI in
California, we would have lower mortality rates for PCI.
Dr Larry Cohn (Boston, Mass). I enjoyed your article. This is
the kind of information that really needs to be publicized. I noted
that one of your sponsoring groups was the Blue Cross Blue Shield.
My question to you is, have any of these data made any impact on
reimbursement for these procedures in the State of California, or
has it actually caused the payers to say you are going to have just
a limited number of PCIs, but we are not going to let you do it in
certain patients, and we think surgery is actually better in the
long run, especially with the internal thoracic bypass and this
kind of thing. Has this had any impact on the payers in terms of de-
termining who gets what or who does not get what?
Dr Carey. That is a good question. I think there is going to be
a big delay in the impact of this kind of information at the upper
echelons of these insurance companies, and this is something that
we yet to deal with. Dan Ullyot was on the board of the Blue
Shield of California Foundation, and he is the one who suggested
that we apply for funding. He might have some information
about that. I believe he is still on the board of that foundation.
I do think it is good for us to get involved with these insurance
companies so that we can help steer their thinking in what we
think is the right direction.
Unidentified Speaker. Dr Carey, this is a great study. Our state
does not have public reporting, and certainly if you publish this we
are going to follow your lead. You report high and low-volume as
greater than 100 CABG procedures per year. I am curious if you
looked at other numbers, and why did you choose 100 as a defini-
tion of high volume?
Dr Carey. We chose that number before because 100 cases per
year is 2 coronary bypass graft cases per week. That is a not a lot
obviously, but hospitals with 2 coronary bypass grafts or more
have an average volume of at least more than 200 cases per
year. Now as we are performing fewer and fewer procedures, the
definition of high volume is changing. There is an article in this
month’s Journal of Thoracic and Cardiovascular Surgery about
the volumes in Japan, where they are even lower than they are
in California. Apparently they have lots of little programs in Japan
and achieve good outcomes there, even in the lower-volume pro-
grams. High volume is really probably more than 100, but for
the purposes of our study, it splits it right in half, making a fairly
equal comparison.
Unidentified Speaker. That is interesting, because in Japan
there are typically 3 surgeons for every bypass operation, 3 cardiac
surgeons. They have somebody harvesting a vein, somebody har-
vesting a thoracic artery, and somebody actually performing the op-
eration. In fact, that is how I believe they keep their surgeon
volumes up, although their case volumes are not great.rgery c November 2009
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DAPPENDIX 1.
Variables were selected for the regression model on the basis
of known relevance from previous studies and on the ability
to discriminate the risk factors using available codes. The
following risk factors were used in the analysis: age catego-
rized as less than 40 years, 40 to 44 years, 45 to 49 years, 50
to 59 years, 55 to 59 years, 60 to 64 years, 65 to 69 years, 70
to 74 years, 75 to 79 years, 80 to 84 years, 85 to 89 years, 90
years or older; gender, race categorized as white, black,
Asian/Pacific Islander, or other race; Hispanic origin; dialy-
sis before surgery or on day of surgery (39.95, 54.98); dia-
betes (250.0, 250.1, 250.2, 250.3, 250.4, 250.5, 250.6,
250.7, 250.9); cerebrovascular disease present at admissionThe Journal of Thoracic and C(430, 431, 432, 433, 434, 435, 436, 437, 438); peripheral
vascular disease present at admission (440.xx, 441.2,
441.4, 441.7, 441.9, 443.1, 443.8, 443.9, 447.1, 557.1,
557.9, V43.4); renal failure present at admission (403.11,
403.91, 404.12, 404.92, 585.xx, 586.xx, V42.0, V45.1,
V56.0, V56.8); cardiomyopathy present at admission
(425.xx); cardiogenic shock present at admission (785.51);
acute MI present at admission (410.xx, 412.xx); congestive
heart failure (428.0, 428.1, 428.9, 398.91, 402.21, 402.11,
402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93);
prior CABG surgery (V45.81); urgent acuity (emergency
admission with surgery on admission day).ardiovascular Surgery c Volume 138, Number 5 1107
